A 1 and A2A receptor subtypes modulate metabolism in adult mammals. This study was designed to determine the role of these receptors in regulating plasma levels of insulin, glucose, and lactate in 20 chronically catheterized fetal sheep (Ͼ0.8 term). In normoxic fetuses (Pa O 2 ϳ24 Torr), systemic blockade of A1 receptors with DPCPX (n ϭ 6) increased plasma concentrations of insulin, glucose, and lactate, but antagonism of A 2A receptors with ZM-241385 (n ϭ 5) had no significant effects. Intravascular administration of adenosine (n ϭ 9) reduced insulin concentrations and elevated glucose and lactate levels. DPCPX (n ϭ 6) augmented the glycemic and lactatemic responses of adenosine. In contrast, ZM241385 (n ϭ 5) virtually abolished adenosine-induced hyperglycemia and hyperlactatemia. Isocapnic hypoxia (Pa O 2 ϳ13 Torr) suppressed insulinemia and enhanced glycemia and lactatemia, but only the hyperglycemia was blunted by blockade of A1 (n ϭ 6) or A2A (n ϭ 6) receptors. We conclude that 1) endogenous adenosine via A1 receptors depresses plasma concentrations of insulin, glucose, and lactate; 2) exogenous adenosine via A2A receptors increases glucose and lactate levels, but these responses are dampened by stimulation of A1 receptors; and 3) hypoxia, which increases endogenous adenosine concentrations, induces hyperglycemia that is partly mediated by activation of A1 and A2A receptors. We predict that adenosine, via A1 receptors, facilitates at least 12% of glucose uptake and utilization in normoxic fetuses. fetus; hypoxia; metabolism; growth; placenta ADENOSINE REGULATES GLUCOSE metabolism in mammals through several mechanisms that include inhibiting insulin secretion by islet cells, altering insulin transduction, and facilitating intracellular glucose transport. Interstitial levels of adenosine increase substantially in hypoxia, hypoglycemia, or heightened cellular metabolism that can occur through intense neuronal activity or skeletal muscle contractions. The physiological effects of adenosine are mediated through activation of G protein-liganded cell surface receptors that are subdivided into four adenosine receptor subtypes: A 1 , A 2A , A 2B , and A 3 (45). These receptors are connected to classical second-messenger pathways that modulate intracellular cAMP production, phospholipase C pathway, and mitogen-activated protein kinases (45,46). With regard to cAMP, stimulation of A 1 receptors, via inhibition of adenylyl cyclase, generally inhibits intracellular cAMP synthesis, while activation of A 2A and A 2B receptors has the opposite effects.Glucose promotes A 1 and A 2A expression in rat cardiac fibroblasts, while insulin suppresses the expression of A 1 and A 2B receptors (11). Insulin also facilitates the equilibrative transcellular movement of adenosine through stimulation of nucleoside transporters in human umbilical vein endothelial cells (37). Adenosine, in turn, inhibits insulin release via activation of islet A 1 receptors (21, 51). Stimulation of A 1 receptors also enhances glucose uptake in tissues thr...